Skip to main content

Table 1 Demographic and clinical characteristics of enrolled subjects

From: Prevalence of sexual activity and associated factors in hypertensive males and females in China: A cross-sectional study

 

Hypertensive group

Normotensive group

Demographic characteristics

Men (n = 225)

Women (n = 277)

Men (n = 82)

Women (n = 91)

Age, mean±SD

48.79 ± 7.39

48.26 ± 6.93

45.69 ± 6.58

46.49 ± 7.26

Blood pressure, mean±SD

SBP:149.80 ± 11.13 DBP:97.74 ± 8.43

151.87 ± 11.13 95.76 ± 8.04

SBP:121.15 ± 9.70 DBP:78.90 ± 8.67

117.10 ± 11.96 73.85 ± 9.89

Educational level

    

Primary school

34 (15.1)

139 (50.2)

7 (8.5)

8 (8.8)

High school

149 (66.2)

123 (44.4)

29 (35.3)

53 (58.2)

University

42 (18.7)

15 (5.4)

46 (56.2)

30 (33.0)

Occupational status

    

Retired or unemployed

42 (18.7)

184 (66.4)

36 (43.9)

34 (37.4)

Professional

147 (65.3)

59 (21.3)

27 (32.9)

40 (43.9)

Physical labor

36 (16.0)

34 (12.3)

19 (23.2)

17 (18.7)

Income (RMB)

    

≤1000

37 (16.4)

194 (70.0)

8 (9.7)

47 (51.6)

1001 ~ 3000

129 (57.3)

74 (26.7)

62 (75.6)

38 (41.8)

≥3000

59 (26.2)

9 (3.2)

12 (14.6)

6 (6.6)

Cigarette smoking

    

Never

85 (37.8)

271 (97.8)

34 (41.5)

86 (94.5)

Moderate

28 (12.4)

6 (2.2)

21 (25.6)

3 (3.2)

Heavy

112 (49.8)

0

27 (32.9)

2 (2.3)

Alcohol consumption

    

Never

106 (47.1)

262 (94.6)

31 (37.8)

54 (59.3)

Moderate

80 (35.6)

14 (5.1)

29 (35.4)

25 (27.5)

Heavy

39 (17.3)

1 (0.4)

22 (26.8)

12 (13.2)

Tea drinking

    

Never

16 (7.1)

48 (17.3)

16 (19.5)

16 (17.6)

Moderate

53 (23.6)

95 (34.3)

24 (29.3)

34 (37.4)

Heavy

156 (69.3)

134 (48.4)

42 (51.2)

41 (45.0)

Medication use

    

ACEI/ARB

32 (14.2)

23 (8.3)

β blockers

8 (3.6)

9 (3.2)

CCB

28 (12.4)

37 (13.4)

Diuretics or others

14 (6.2)

17 (6.1)

No medication

143 (63.6)

191 (69)

  1. Data are number (%) unless indicated.
  2. SBP, systolic blood pressure; DBP, diastolic blood pressure; ACE1/ARB, angiotensin-converting enzym 1/angiotensin receptor blocker; CCB, calcium channel blocker.